No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...

A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.

Jessica Ko saw others sharing their DNA results online and decided to take a test. The results have changed how she sees ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended ...

Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

(133) :15 this has been a nightmare since day oneIf the act of jaws dropping made a sound, the Tulsa county courthouse would ...

You don’t have to wait for Walmart’s actual Black Friday sale: These stellar discounts on Wirecutter-approved products are ...

Ten years after her sexual assault, she discovered that the evidence in her rape kit hadn’t been tested — and neither had ...

The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...

Consumer demand for its DNA-testing kits has dropped sharply over time and it has become evident that consumers, once they have received their test results, have no further use for the product or ...

The once-high-flying firm has been beset by challenges since going public via a SPAC merger in 2021. Here’s the latest.

23andMe Holding Co.'s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, shedding gains made late Monday after it announced it would cut 40% of its ...